Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Kingchem
301509
5
Hunan Er-kang Pharmaceutical
300267
US Stock MarketDetailed Quotes
HUM Humana
- 267.830
- +4.220+1.60%
Close Apr 24 16:00 ET
- 267.830
- 0.0000.00%
Post 16:41 ET
32.33BMarket Cap26.84P/E (TTM)
268.010High259.750Low1.06MVolume261.390Open263.610Pre Close281.77MTurnover0.88%Turnover Ratio26.84P/E (Static)120.69MShares402.60152wk High1.97P/B32.25BFloat Cap211.87252wk Low3.54Dividend TTM120.43MShs Float557.961Historical High1.32%Div YieldTTM3.13%Amplitude4.213Historical Low265.553Avg Price1Lot Size
Humana Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 10.70%117.76B | 10.40%29.21B | 11.26%29.4B | 10.44%29.54B | 10.73%29.61B | 14.54%106.37B | 17.93%26.46B | 15.90%26.42B | 13.04%26.75B | 11.56%26.74B |
| Total premiums earned | 10.70%112.1B | 10.43%27.75B | 11.36%27.95B | 10.38%28.14B | 10.61%28.26B | 15.46%101.27B | 18.11%25.13B | 16.91%25.1B | 14.50%25.5B | 12.54%25.55B |
| Net investment income | 14.69%1.23B | 1.02%297M | 11.36%343M | 8.76%298M | 49.22%288M | 179.84%1.07B | 83.75%294M | 79.07%308M | 482.98%274M | 6,333.33%193M |
| Fee revenue and other income | 9.87%4.43B | 12.12%1.17B | 8.56%1.1B | 12.47%1.1B | 6.31%1.06B | -15.56%4.03B | 3.59%1.04B | -12.34%1.02B | -27.50%978M | -20.97%999M |
| -Fees and commissions | 9.87%4.43B | 12.12%1.17B | 8.56%1.1B | 12.47%1.1B | 6.31%1.06B | -15.56%4.03B | 3.59%1.04B | -12.34%1.02B | -27.50%978M | -20.97%999M |
| Total expenses | 12.67%116.04B | 11.17%30.08B | 13.51%28.75B | 12.31%28.62B | 13.81%28.6B | 15.33%102.99B | 20.18%27.05B | 17.78%25.33B | 13.07%25.49B | 10.45%25.13B |
| Loss adjustment expense | 13.88%100.66B | 11.41%25.38B | 15.52%25.12B | 13.77%25.04B | 14.94%25.12B | 16.78%88.39B | 22.60%22.78B | 18.28%21.75B | 15.24%22.01B | 11.38%21.86B |
| Depreciation and amortization | 7.70%839M | 3.48%208M | 4.48%210M | 10.99%212M | 12.37%209M | 9.87%779M | 10.44%201M | 10.44%201M | 9.14%191M | 9.41%186M |
| Non-operating net interest income (expenses) | -33.87%-660M | -12.33%-164M | -48.25%-169M | -40.00%-168M | -40.71%-159M | -22.94%-493M | -35.19%-146M | -11.76%-114M | -18.81%-120M | -25.56%-113M |
| -Interest expense-non operating | 33.87%660M | 12.33%164M | 48.25%169M | 40.00%168M | 40.71%159M | 22.94%493M | 35.19%146M | 11.76%114M | 18.81%120M | 25.56%113M |
| Special income (charges) | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Income before tax | -49.13%1.72B | -45.85%-862M | -40.71%651M | -27.26%918M | -37.17%1.01B | -5.18%3.38B | -732.39%-591M | -15.34%1.1B | 12.48%1.26B | 32.30%1.61B |
| Income tax | -50.60%413M | -188.00%-216M | -39.45%155M | -24.66%223M | -30.08%251M | 9.71%836M | -29.31%-75M | 139.25%256M | -30.68%296M | 25.52%359M |
| Earnings from equity interest net of tax | -49.21%-94M | -54.17%-37M | -33.33%-16M | -70.00%-17M | -41.18%-24M | -1,475.00%-63M | -380.00%-24M | -500.00%-12M | -600.00%-10M | -325.00%-17M |
| Net income | -51.13%1.21B | -26.48%-683M | -42.17%480M | -29.08%678M | -40.31%739M | -11.35%2.48B | -2,900.00%-540M | -30.43%830M | 37.16%956M | 33.12%1.24B |
| Net Income continuous operations | -51.13%1.21B | -26.48%-683M | -42.17%480M | -29.08%678M | -40.31%739M | -11.35%2.48B | -2,900.00%-540M | -30.43%830M | 37.16%956M | 33.12%1.24B |
| Minority interest income | 240.00%7M | 900.00%10M | 0 | 66.67%-1M | -100.00%-2M | -25.00%-5M | 133.33%1M | 0.00%-2M | -400.00%-3M | -1M |
| Net income attributable to the parent company | -51.51%1.21B | -28.10%-693M | -42.31%480M | -29.20%679M | -40.19%741M | -11.30%2.49B | -3,506.67%-541M | -30.38%832M | 37.79%959M | 33.23%1.24B |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -51.51%1.21B | -28.10%-693M | -42.31%480M | -29.20%679M | -40.19%741M | -11.30%2.49B | -3,506.67%-541M | -30.38%832M | 37.79%959M | 33.23%1.24B |
| Basic earnings per share | -50.17%10.01 | -30.32%-5.76 | -40.80%3.99 | -26.88%5.63 | -38.14%6.13 | -9.50%20.09 | -3,583.33%-4.42 | -28.68%6.74 | 40.00%7.7 | 35.38%9.91 |
| Diluted earnings per share | -50.10%9.98 | -30.32%-5.76 | -40.69%3.98 | -26.63%5.62 | -38.10%6.11 | -9.42%20 | -3,583.33%-4.42 | -28.54%6.71 | 39.78%7.66 | 35.39%9.87 |
| Dividend per share | 0.00%3.54 | 0.00%0.885 | 0.00%0.885 | 0.00%0.885 | 0.00%0.885 | 12.38%3.54 | 12.38%0.885 | 12.38%0.885 | 12.38%0.885 | 12.38%0.885 |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Market Insights
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now